19920-80-0 Usage
Description
1-(4-bromophenyl)cyclohexan-1-ol is an organic compound characterized by its molecular formula C12H15BrO. It is a white solid that exhibits solubility in organic solvents but not in water. As a secondary alcohol, it features a hydroxyl group attached to a secondary carbon atom. 1-(4-bromophenyl)cyclohexan-1-ol's unique chemical properties, stemming from the bromine atom and the phenyl group, make it a versatile intermediate for the synthesis of other organic compounds and a valuable asset in the pharmaceutical and chemical industries. Additionally, it is utilized in research and development laboratories for the preparation of specialty chemicals.
Uses
Used in Pharmaceutical Industry:
1-(4-bromophenyl)cyclohexan-1-ol is used as an intermediate in the synthesis of various pharmaceutical compounds due to its unique chemical properties and reactivity. The presence of the bromine atom and the phenyl group allows for a wide range of organic reactions, making it a valuable building block for the development of new drugs and therapeutic agents.
Used in Chemical Industry:
In the chemical industry, 1-(4-bromophenyl)cyclohexan-1-ol is employed as a key intermediate for the production of other organic compounds. Its unique structure and reactivity make it suitable for various applications, including the synthesis of specialty chemicals, dyes, and other industrial products.
Used in Research and Development Laboratories:
1-(4-bromophenyl)cyclohexan-1-ol is utilized in research and development laboratories for the preparation of specialty chemicals. Its unique chemical properties and reactivity make it an essential tool for scientists and researchers working on the development of new chemical processes and products.
Check Digit Verification of cas no
The CAS Registry Mumber 19920-80-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,9,2 and 0 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 19920-80:
(7*1)+(6*9)+(5*9)+(4*2)+(3*0)+(2*8)+(1*0)=130
130 % 10 = 0
So 19920-80-0 is a valid CAS Registry Number.
19920-80-0Relevant articles and documents
THERAPEUTIC COMPOUNDS
-
Paragraph 00576-00578, (2021/06/04)
The present disclosure relates to compounds of formula (I) and pharmaceutically acceptable salts thereof, and compositions and uses thereof. The compounds are useful as inhibitors of the YAP:TEAD protein:protein interaction. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various YAP:TEAD-mediated disorders, including cancer.
Flow-Assisted Synthesis of [10]Cycloparaphenylene through Serial Microreactions under Mild Conditions
Kim, Heejin,Lee, Hyune-Jea,Kim, Dong-Pyo
supporting information, p. 1422 - 1426 (2016/02/14)
Cycloparaphenylene (CPP) has been recognized as an attractive template for the bottom-up synthesis of carbon nanotubes with uniform diameter, and is important for the chemistry of graphitic as well as ring-shaped macromolecules. However, the reported rout
Enantioselective photoredox catalysis enabled by proton-coupled electron transfer: Development of an asymmetric aza-pinacol cyclization
Rono, Lydia J.,Yayla, Hatice G.,Wang, David Y.,Armstrong, Michael F.,Knowles, Robert R.
supporting information, p. 17735 - 17738 (2014/01/06)
The first highly enantioselective catalytic protocol for the reductive coupling of ketones and hydrazones is reported. These reactions proceed through neutral ketyl radical intermediates generated via a concerted proton-coupled electron transfer (PCET) event jointly mediated by a chiral phosphoric acid catalyst and the photoredox catalyst Ir(ppy)2(dtbpy)PF6. Remarkably, these neutral ketyl radicals appear to remain H-bonded to the chiral conjugate base of the Bronsted acid during the course of a subsequent C-C bond-forming step, furnishing syn 1,2-amino alcohol derivatives with excellent levels of diastereo- and enantioselectivity. This work provides the first demonstration of the feasibility and potential benefits of concerted PCET activation in asymmetric catalysis.
